About CoreRx
CoreRx is a company based in Clearwater (United States) founded in 2006 was acquired by NovaQuest Capital Management in January 2021.. CoreRx has raised $15 million across 4 funding rounds from investors including Florida High Tech Corridor, Signet Healthcare Partners and NovaQuest Capital Management. CoreRx has completed 1 acquisition, including Societal CDMO. CoreRx offers products and services including Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms. CoreRx operates in a competitive market with competitors including Unither, Akums, Recipharm, Jubilant Life Sciences and Windlas, among others.
- Headquarter Clearwater, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Corerx Pharma India Private Limited
- Date of Incorporation 13 May, 2021
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$387.69 K (USD)170.39as on Mar 31, 2023
-
Net Profit
$86.78 K (USD)438.53as on Mar 31, 2023
-
EBITDA
$101.84 K (USD)307.24as on Mar 31, 2023
-
Total Equity Funding
$15 M (USD)
in 4 rounds
-
Latest Funding Round
$3 M (USD), Series A
Mar 21, 2019
-
Investors
Florida High Tech Corridor
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
NovaQuest Capital Management
(Jan 19, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CoreRx
CoreRx offers a comprehensive portfolio of products and services, including Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops and commercializes particle-based drug delivery systems
Engineers solutions for inhaled and bioavailability-enhanced drugs
Produces intermediate and modified release formulations
Unlock access to complete
Funding Insights of CoreRx
CoreRx has successfully raised a total of $15M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $3.0M
-
First Round
First Round
(24 Jun 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2019 | Amount | Series A - CoreRx | Valuation |
investors |
|
| Apr, 2017 | Amount | Series A - CoreRx | Valuation |
investors |
|
| Mar, 2015 | Amount | Series A - CoreRx | Valuation | Signet Healthcare Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CoreRx
CoreRx has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Florida High Tech Corridor, Signet Healthcare Partners and NovaQuest Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Founded Year | Domain | Location | |
|
PE firm focused on life science and healthcare companies
|
Founded Year | Domain | Location | |
|
The Florida High Tech Corridor is focused on regional high-tech development.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CoreRx
CoreRx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Societal CDMO. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of clinical trial, formulation development, packaging, and quality assurance services
|
1982 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - CoreRx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Corerx Comparisons
Competitors of CoreRx
CoreRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Recipharm, Jubilant Life Sciences and Windlas, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Biopharma regulatory affairs, quality control, and strategy services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Corerx
Frequently Asked Questions about CoreRx
When was CoreRx founded?
CoreRx was founded in 2006 and raised its 1st funding round 7 years after it was founded.
Where is CoreRx located?
CoreRx is headquartered in Clearwater, United States. It is registered at Clearwater, Florida, United States.
Is CoreRx a funded company?
CoreRx is a funded company, having raised a total of $15M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Jun 24, 2013.
What is the annual revenue of CoreRx?
Annual revenue of CoreRx is $387.69K as on Mar 31, 2023.
What does CoreRx do?
CoreRx was founded in 2006 in Clearwater, United States, as a contract development and manufacturing organization in the pharmaceutical sector. A range of cGMP-compliant services is offered, including pre-formulation, analytical development, product formulation, and clinical manufacturing. Support is provided for solid oral dosage forms, semi-solids, liquids, and API packaging. Operations focus on accelerating entry into clinical trials through certified facilities and technical services.
Who are the top competitors of CoreRx?
CoreRx's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does CoreRx offer?
CoreRx offers Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms.
How many acquisitions has CoreRx made?
CoreRx has made 1 acquisition, including Societal CDMO.
Who are CoreRx's investors?
CoreRx has 3 investors. Key investors include Florida High Tech Corridor, Signet Healthcare Partners, and NovaQuest Capital Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.